Lonza Group AG
LONN
Pozycja w akcjach
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Cena akcji
$766.95
Kapitalizacja rynkowa
$53.57B
Zmiana (1 dzień)
1.35%
Zmiana (1 rok)
9.01%
Kraj
CH
Handel Lonza Group AG (LONN)
Kategoria
Healthcare
EPS dla Lonza Group AG (LONN)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Lonza Group AG, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Lonza Group AG od 2004 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2025 | $-4.95 | -150.09% |
| 2024 | $9.89 | -6.37% |
| 2023 | $10.56 | -40.37% |
| 2022 | $17.71 | -59.29% |
| 2021 | $43.49 | 234.48% |
| 2020 | $13.00 | 44.08% |
| 2019 | $9.02 | 18.21% |
| 2018 | $7.63 | -23.92% |
| 2017 | $10.03 | 78.24% |
| 2016 | $5.63 | 6.18% |
| 2015 | $5.30 | 15.51% |
| 2014 | $4.59 | 145.27% |
| 2013 | $1.87 | -44.92% |
| 2012 | $3.40 | 15.65% |
| 2011 | $2.94 | -46.58% |
| 2010 | $5.50 | 92.65% |
| 2009 | $2.85 | -62.63% |
| 2008 | $7.64 | 47.35% |
| 2007 | $5.18 | 45.65% |
| 2006 | $3.56 | 27.31% |
| 2005 | $2.80 | 17.74% |
| 2004 | $2.37 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| $27.74 | - |
NL
|
|
| $13.70 | - |
BE
|
